NHS Innovation Accelerator
Tim Ringrose is an experienced leader in the healthcare sector, currently serving as a NIA Fellow at the NHS Innovation Accelerator since March 2024. Holding the position of Chief Executive Officer at Cognitant Group Limited since March 2018, Tim also contributes as a Strategic Advisor at Candesic and has held multiple non-executive director roles at Qured and eConsult.webGP until March 2024. Tim's leadership extends to the Royal Society of Medicine, where Tim was President of the Digital Health Section from September 2021 to October 2023. Additional roles include advising Claritas HealthTech and serving as an external board member for the Royal College of General Practitioners' Innovation and Research Programme. Previous experience includes serving as CEO of M3 EU and Doctors.net.uk. Tim holds a BSc Hons in Medical Science from the University of St Andrews and an MB BCh in Medicine from Cardiff University.
This person is not in the org chart
This person is not in any teams
NHS Innovation Accelerator
1 followers
The NHS Innovation Accelerator (NIA) is an NHS England Initiative delivered in partnership with the country’s 15 Health Innovation Networks (HINs) and the Accelerated Access Collaborative. Hosted by UCLPartners, it supports delivery of the Five Year Forward View by accelerating uptake of high impact innovations for patient, population and NHS staff benefit, and providing real time practical insights on spread to inform national strategy. Fellows supported by the NIA all share a set of values and passion for scaling evidence-based innovation to benefit a wider population, with a commitment to share their learnings. Some impressive results have been achieved by Fellows since the NIA launched in July 2015: 2,980 additional NHS sites now using NIA innovations; £203 million in external funds secured; 193 awards won; 1,145 jobs created; and 57 innovations selling internationally. In addition, impact data is already available at adopter sites and this demonstrates earlier intervention, reductions in complications and emergency admissions, alongside cost savings.